These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27273898)

  • 1. Identifying a robust design space for glycosylation during monoclonal antibody production.
    St Amand MM; Hayes J; Radhakrishnan D; Fernandez J; Meyer B; Robinson AS; Ogunnaike BA
    Biotechnol Prog; 2016 Sep; 32(5):1149-1162. PubMed ID: 27273898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of manipulated variables for a glycosylation control strategy.
    St Amand MM; Radhakrishnan D; Robinson AS; Ogunnaike BA
    Biotechnol Bioeng; 2014 Oct; 111(10):1957-70. PubMed ID: 24728980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody.
    Pace D; Lewis N; Wu T; Gillespie R; Leiske D; Velayudhan J; Rohrbach A; Connell-Crowley L
    Biotechnol Prog; 2016 Sep; 32(5):1181-1192. PubMed ID: 27160519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.
    Agarabi CD; Schiel JE; Lute SC; Chavez BK; Boyne MT; Brorson KA; Khan M; Read EK
    J Pharm Sci; 2015 Jun; 104(6):1919-1928. PubMed ID: 25762022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of media and antifoam selection on monoclonal antibody production and quality using a high throughput micro-bioreactor system.
    Velugula-Yellela SR; Williams A; Trunfio N; Hsu CJ; Chavez B; Yoon S; Agarabi C
    Biotechnol Prog; 2018 Jan; 34(1):262-270. PubMed ID: 29086492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of orbitally-shaken and stirred-tank bioreactors: pH modulation and bioreactor type affect CHO cell growth and protein glycosylation.
    Monteil DT; Juvet V; Paz J; Moniatte M; Baldi L; Hacker DL; Wurm FM
    Biotechnol Prog; 2016 Sep; 32(5):1174-1180. PubMed ID: 27453130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of site-distinct N-glycan variants for in vitro bioactivity testing.
    Brühlmann D; Vuillemin T; Satwekar A; Galano E; Palmese A; D'Angelo A; Manco Z; Souquet J; Broly H; Sauer M; Hemberger J; Jordan M
    Biotechnol Bioeng; 2019 May; 116(5):1017-1028. PubMed ID: 30659587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-linked glycosylation is an important parameter for optimal selection of cell lines producing biopharmaceutical human IgG.
    van Berkel PH; Gerritsen J; Perdok G; Valbjørn J; Vink T; van de Winkel JG; Parren PW
    Biotechnol Prog; 2009; 25(1):244-51. PubMed ID: 19224598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody.
    Agarabi CD; Chavez BK; Lute SC; Read EK; Rogstad S; Awotwe-Otoo D; Brown MR; Boyne MT; Brorson KA
    Biotechnol Prog; 2017 Jan; 33(1):163-170. PubMed ID: 27813291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.
    Zhong X; Ma W; Meade CL; Tam AS; Llewellyn E; Cornell R; Cote K; Scarcelli JJ; Marshall JK; Tzvetkova B; Figueroa B; DiNino D; Sievers A; Lee C; Guo J; Mahan E; Francis C; Lam K; D'Antona AM; Zollner R; Zhu HL; Kriz R; Somers W; Lin L
    Biotechnol Prog; 2019 Jan; 35(1):e2724. PubMed ID: 30299005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan Residues Balance Analysis - GReBA: A novel model for the N-linked glycosylation of IgG produced by CHO cells.
    Zhang L; Wang M; Castan A; Stevenson J; Chatzissavidou N; Hjalmarsson H; Vilaplana F; Chotteau V
    Metab Eng; 2020 Jan; 57():118-128. PubMed ID: 31539564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK; James DC
    Biotechnol Bioeng; 2013 Nov; 110(11):2970-83. PubMed ID: 23737295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time monitoring of antibody glycosylation site occupancy by in situ Raman spectroscopy during bioreactor CHO cell cultures.
    Li MY; Ebel B; Paris C; Chauchard F; Guedon E; Marc A
    Biotechnol Prog; 2018 Mar; 34(2):486-493. PubMed ID: 29314747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycan profiling of proteins using lectin binding by Surface Plasmon Resonance.
    Wang W; Soriano B; Chen Q
    Anal Biochem; 2017 Dec; 538():53-63. PubMed ID: 28947169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions.
    Blondeel EJM; Aucoin MG
    Biotechnol Adv; 2018; 36(5):1505-1523. PubMed ID: 29913209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of media composition on recombinant monoclonal IgA1 glycosylation analysed by lectin-based protein microarray and MALDI-MS.
    Pažitná L; Nemčovič M; Pakanová Z; Baráth P; Aliev T; Dolgikh D; Argentova V; Katrlík J
    J Biotechnol; 2020 May; 314-315():34-40. PubMed ID: 32298669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-based investigation of intracellular processes determining antibody Fc-glycosylation under mild hypothermia.
    Sou SN; Jedrzejewski PM; Lee K; Sellick C; Polizzi KM; Kontoravdi C
    Biotechnol Bioeng; 2017 Jul; 114(7):1570-1582. PubMed ID: 27869292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning a MAb glycan profile in cell culture: Supplementing N-acetylglucosamine to favour G0 glycans without compromising productivity and cell growth.
    Blondeel EJ; Braasch K; McGill T; Chang D; Engel C; Spearman M; Butler M; Aucoin MG
    J Biotechnol; 2015 Nov; 214():105-12. PubMed ID: 26387447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.